Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease

MLA

M.C. Gagnieu, et al. “Cerebrospinal Fluid Immunoreactive Substance P and Somatostatin in Neurological Patients with Peripheral and Spinal Cord Disease.” Neuropeptides, vol. 12, Oct. 1988, pp. 119–24. EBSCOhost, https://doi.org/10.1016/0143-4179(88)90041-8.

APA

M.C. Gagnieu, K. Rissler, N. Rösler, B. Renaud, & H. Cramer. (1988). Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease. Neuropeptides, 12, 119–124. https://doi.org/10.1016/0143-4179(88)90041-8

Chicago

M.C. Gagnieu, K. Rissler, N. Rösler, B. Renaud, and H. Cramer. 1988. “Cerebrospinal Fluid Immunoreactive Substance P and Somatostatin in Neurological Patients with Peripheral and Spinal Cord Disease.” Neuropeptides 12 (October): 119–24. doi:10.1016/0143-4179(88)90041-8.